Open AccessIs adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients?
Author(s) -
Haluk Sargın,
Mehmet Sargın,
Hülya Ilıksu Gözü,
Asuman Orçun,
Gülcan Baloglu,
Murat Ozisik,
Mesut Şeker,
Oya Uygur-Bayramiçli
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i37.5874
Subject(s) - adiponectin , medicine , nonalcoholic fatty liver disease , endocrinology , insulin resistance , proinsulin , body mass index , insulin , fatty liver , homeostatic model assessment , diabetes mellitus , disease
Adiponectin is a hepatic insulin sensitizer and also an inhibitor of tumor necrosis factor. We studied its levels in nondiabetic patients with nonalcoholic fatty liver disease (NAFLD) and compared with control group.